10182017Headline:

Dallas-Fort Worth, Texas

HomeTexasDallas-Fort Worth

Email Shezad Malik MD JD Shezad Malik MD JD on LinkedIn Shezad Malik MD JD on Twitter Shezad Malik MD JD on Facebook Shezad Malik MD JD on Avvo
Shezad Malik MD JD
Shezad Malik MD JD
Attorney • (888) 210-9693

NuvaRing DVT and Pulmonary Embolism Lawsuits Tops 1,500

Comments Off

According to Merck company filings, there are now about 1,500 filed product liability lawsuits involving injuries from NuvaRing blood clots. These women are claiming that the contraceptive ring increased the risk of blood clots and other side effects.

nuvaring pulmonary embolism attorneyWhat is Nuvaring?

NuvaRing is a vaginal contraceptive ring, made by Merck’s Organon subsidiary, which is placed in the vagina. The ring releases a combination of estrogen, ethinyl estradiol and the “third generation” progestin, etonogestrel.

Merck indicates that the majority of the cases are in the U.S. District Court for the Eastern District of Missouri before Judge Sippel as part of an MDL, or Multi-District Litigation.

According to Merck, there are about 1,285 cases in the NuvaRing MDL, and about 200 lawsuits in the New Jersey state court system, where they have been centralized in Bergen County Superior Court.

There are also 9 cases pending in various other state courts, including two cases that are being coordinated in the San Francisco Superior Court in California.

NuvaRing Injury Claims

The NuvaRing injury lawsuits involve allegations that the birth control ring increases the risk of blood clots compared to other forms of contraception.

Furthermore, that Merck’s Organon subsidiary failed to warn women or doctors about the risk of a pulmonary embolism, deep vein thrombosis (DVT), stroke or other blood-clot injury.

NuvaRing Settlement Negotiations In Progress

A group of cases are being prepared for early trial dates, known as “bellwether” lawsuits.

The first NuvaRing trial, involving a lawsuit filed by Marianna Prather, is now scheduled to begin January 27, 2014, and the parties have been ordered to continue discussions with a mediator to review potential resolutions for the litigation.

The parties are quietly confident that a global settlement may be announced in the coming months, but if settlement talks break down, then the bellwether trial outcomes may force Merck’s hand.